What changed
$TME — BUY 📊 | 6 MONTHS THESIS
🎯 latest | Rev $4.3B | EPS $1.46 vs $1.43 🟢
💡 Consensus expects flattish earnings due to regulatory and macro headwinds, but the company is delivering margin expansion and stable cash flows, with potential for re-rating as it returns capital and improves profit mix.
📉 Reward/risk: 2.36:1
🏢 Business Quality: 7/10 - Strong competitive moat, high cash generation, but regulatory risk and single-market exposure.
📊 Valuation: cheap — 12x forward non-IFRS P/E, 9% FCF yield, 8.5x EV/EBITDA, versus historical 20x and peer group 15-20x. Fair value range $10.50–$12.50.
🔮 Catalyst: Upcoming Q1 2025 earnings in May 2025 could show sustained margin improvement and subscription growth; potential expanded buyback announcement.
💰 Entry: $8.69, stop $7.5, target $11.5
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/TME0617